Gestational Diabetes Market to witness growth by 2032, estimates DelveInsight | Antares Pharma, 3M, Eli Lilly, Sanofi, Novo Nordisk, Abbott, AstraZeneca, Novartis, Daiichi Sankyo, Boehringer Ingelheim

Source :: M2 Presswire. December 13, 2023
Publication Year :: 2023
Abstract: M2 PRESSWIRE-December 13, 2023-: Gestational Diabetes Market to witness growth by 2032, estimates DelveInsight | Antares Pharma, 3M, Eli Lilly, Sanofi, Novo Nordisk, Abbott, AstraZeneca, Novartis, Daiichi Sankyo, Boehringer Ingelheim [...]

Subjects :: Antares Pharma -- Forecasts and trends -- Growth
Boehringer Ingelheim GmbH -- Forecasts and trends -- Growth
Novartis AG -- Forecasts and trends -- Growth
AstraZeneca PLC -- Forecasts and trends -- Growth
Eli Lilly and Co. -- Forecasts and trends -- Growth
Novo Nordisk A/S -- Forecasts and trends -- Growth
Sanofi S.A. -- Forecasts and trends -- Growth
Business -- Research
Diabetes therapy -- Reports -- Forecasts and trends
Diabetes in pregnancy -- Reports -- Forecasts and trends
Brand equity -- Forecasts and trends -- Reports
Epidemiology -- Forecasts and trends -- Reports
Type 2 diabetes -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends -- Growth
Company growth
Market trend/market analysis
Business
Business, international

Tools